Molecular Cancer Therapeutics, 1535-7163

Journal

Publications

  1. Published
  2. Published

    Anticancer properties of a novel class of tetrafluorinated thalidomide analogues

    Chris Mahony, Oct 2015, In : Molecular Cancer Therapeutics. 14, 10, p. 2228–2237 10 p.

    Research output: Contribution to journalArticlepeer-review

  3. Published
  4. Published
  5. Published
  6. Published
  7. Published

    Targeted mutations in the ATR pathway define agent-specific requirements for cancer cell growth and survival

    Eva Petermann, Jan 2012, In : Molecular Cancer Therapeutics. 11, 1, p. 98-107 10 p.

    Research output: Contribution to journalArticlepeer-review

  8. Published
  9. Published